Peroxisome proliferator-activated receptor delta
Peroxisome proliferator-activated receptor delta (PPAR-δ), also known as PPARD, is a protein that in humans is encoded by the PPARD gene. It is a member of the peroxisome proliferator-activated receptors (PPARs) family, which are nuclear receptor proteins that function as transcription factors regulating the expression of genes.
Function[edit]
PPAR-δ is involved in many biological processes, including lipid metabolism, glucose homeostasis, inflammation, and wound healing. It plays a crucial role in the regulation of fatty acid oxidation, energy metabolism, and insulin sensitivity. PPAR-δ activation has been shown to increase HDL cholesterol and decrease triglycerides levels in the blood.
Clinical significance[edit]
PPAR-δ has been implicated in several diseases, including obesity, diabetes, atherosclerosis, and cancer. It is a potential therapeutic target for the treatment of metabolic diseases and certain types of cancer. Several PPAR-δ agonists are currently under investigation for their potential therapeutic effects.
Structure[edit]
The PPAR-δ protein consists of a DNA-binding domain and a ligand-binding domain. The DNA-binding domain recognizes specific DNA sequences, known as peroxisome proliferator response elements (PPREs), in the promoter region of target genes. The ligand-binding domain binds to specific ligands, leading to the activation of PPAR-δ.
Ligands[edit]
Several natural and synthetic ligands have been identified for PPAR-δ. Natural ligands include certain fatty acids and their derivatives. Synthetic ligands include drugs such as GW501516 and L-165041.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian